"Pseudomonas aeruginosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.
Descriptor ID |
D011550
|
MeSH Number(s) |
B03.440.400.425.625.625.100 B03.660.250.580.590.050
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas aeruginosa".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas aeruginosa".
This graph shows the total number of publications written about "Pseudomonas aeruginosa" by people in this website by year, and whether "Pseudomonas aeruginosa" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pseudomonas aeruginosa" by people in Profiles.
-
Quorum Sensing and Biofilm Disrupting Potential of Imidazole Derivatives in Chromobacterium violaceum Using Antimicrobial and Drug Discovery Approaches. Braz J Microbiol. 2022 Jun; 53(2):565-582.
-
Distribution of serotypes and antibiotic resistance of invasive Pseudomonas aeruginosa in a multi-country collection. BMC Microbiol. 2022 01 06; 22(1):13.
-
Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017. S Afr Med J. 2019 Nov 27; 109(12):934-940.
-
Laboratory based antimicrobial resistance surveillance for Pseudomonas aeruginosa blood isolates from South Africa. J Infect Dev Ctries. 2018 08 31; 12(8):616-624.
-
Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa. S Afr Med J. 2008 Aug; 98(8):626-32.
-
CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils. Pulm Pharmacol Ther. 2000; 13(6):293-9.
-
Exposure of N-formyl-L-methionyl-L-leucyl-L-phenylalanine-activated human neutrophils to the Pseudomonas aeruginosa-derived pigment 1-hydroxyphenazine is associated with impaired calcium efflux and potentiation of primary granule enzyme release. Infect Immun. 1999 Oct; 67(10):5157-62.